- Home
- switzerland
- Companies
Refine by
Medical Industry Technology In Switzerland
26 companies found
Technologybased inWaiblingen, GERMANY
Syntegon stands as a strategic partner in the pharmaceutical and food processing and packaging sectors. Utilizing a heritage of 160 years, Syntegon's portfolio extends to standalone machines and comprehensive system solutions for primary and ...
Technologybased inWadenswil, SWITZERLAND
3Brain is the world’s first company to connect cells with sophisticated silicon chips in cell culture plates. Stemming from our passion for technology and scientific progress, our co-founders have worked for more than 15 years on CMOS-powered ...
BioCAM DupleX is a state-of-the-art, high-resolution microelectrode array (also known as multielectrode array) platform for powerful in vitro functional imaging. Its bidirectional electrodes make it possible to simultaneously record high-density ...
Technologybased inZürich, SWITZERLAND
Amcor is a world leader in innovative packaging. The company added a range of diverse packaging interests to its traditional papermaking activities. This was achieved through creating new business partnerships and making strategic acquisitions in ...
High barrier foil & nylon bags and drum liners for packaging of bulk drugs and active pharmaceutical ...
Technologybased inBethesda, MARYLAND (USA)
Gain Therapeutics is redefining drug discovery with its SEE-Txâ„¢ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for ...
Morquio B, also known as Mucopolysaccharidosis type IV (MPS IV), is a progressive disease mostly impacting the skeleton, caused by mutations in GLB1, the gene that encodes the beta-galactosidase (GLB) enzyme. These mutations result in the misfolding ...
Technologybased inBasel, SWITZERLAND
T3 Pharmaceuticals was founded in May 2015 by Simon Ittig, Christoph Kasper, Marlise Amstutz and Helmut Kessmann as a spin-off of the University of Basel. The team has developed an efficient protein delivery technology that is based on the use of ...
T3 Pharma has developed a proprietary cancer therapy platform based on regulating and harnessing the natural behaviours of live bacteria. The genetically engineered bacteria selectively target solid tumors, where they deliver chosen protein payloads ...
Technologybased inDubendorf, SWITZERLAND
VunaNexus uses a patented technology to transform human and livestock urine into two valuable products: a fertiliser free of all dangerous pollutants and water that can be reused, this while drastically reducing ammonia emissions and water ...
Aurin - The 1st urine fertiliser worldwide with full approval. Aurin is a universal fertiliser made from human urine. Vuna offers the process that converts urine into fertiliser. This removes drug residues, hormones and germs, but the ...
Technologybased inPréverenges, SWITZERLAND
Founded in 2016 by a group of experienced engineers and bio-informaticians under the leadership of Claudio Alberti, our CTO, GenomSys is a Swiss company developing state-of-the-art technology and services for the efficient analysis and secure ...
GenomSys Codec Suite is a collection of software tools to process genomic data compliant with ISO/IEC-23092 genomic data standard (MPEG-G). It is CE marked as an in-Vitro Diagnostic Medical Device according to 98/79/CE directive and hence approved ...
Technologybased inEindhoven, NETHERLANDS
Xeltis is a clinical-stage medical device company pioneering a restorative approach in cardiovascular therapy. RestoreX™, Xeltis technology platform, is the world’s first polymer-based technology designed to enable natural restoration of ...
The XABG device is a restorative, synthetic, electrospun blood vessels for CABG surgery, overtime turning into a living vessel made of patient’s own ...
Technologybased inMaur (Zurich), SWITZERLAND
We are delighted to introduce our current range of modular systems and individual components to you on the following pages. When Rolf Sieber first entered the market with SITEC in 1984, he could never have imagined the success the company enjoys ...
Applying ultra-high-pressure to pharmaceutical or natural products leads to an inactivation of germs without thermal alteration of the ...
Technologybased inBasel, SWITZERLAND
Aurealis Therapeutics, a Swiss-Finnish private biopharmaceutical company, is now entering the clinical trial phase with its patented three-in-one combination product AUP-16 for chronic non-healing wounds and other regenerative diseases. The ...
Technologybased inLausanne, SWITZERLAND
Amazentis is an innovative life science company dedicated to employing breakthrough research and clinical science to bring advanced therapeutic nutrition products to life. We employ rigorous science to pioneer the discovery and clinical development ...
Mitopure® is a highly pure form of Urolithin A, a postbiotic clinically shown to energize cells, increase muscle strength and improve endurance. And this is just the beginning. New studies continuously explore and prove the incredible potential ...
Technologybased inFlamatt, SWITZERLAND
As a trailblazing, leading tech company in radio frequency and x-ray technology, we make a growing contribution to a safer and more secure, more efficient and sustainable world of manufacturing, communication and mobility. For our customers in the ...
Technologybased inLausanne, SWITZERLAND
Xsensio is an innovation-driven digital health company dedicated to solving one of the biggest challenges in healthcare: the lack of real-time, continuous monitoring of relevant health parameters. To achieve this vision, Xsensio is building the ...
Xsensio considerably expands the potential of wearable products with the development of a breakthrough wearable device that tracks – not physical data like today’s devices – but biochemical data in the interstitial fluid (ISF). At ...
Technologybased inGeneve, SWITZERLAND
STALICLA has developed the first neurodevelopmental disorder-specific precision medicine discovery platform with an initial application in autism spectrum disorder (ASD). Until now, patient diagnosis and drug development for ASD and other NDDs have ...
STALICLA’s precision medicine approach begins with ‘endophenotyping’-identifying the nonbehavioral physical and molecular presentations of NDDs and characterizing subgroups of patients with similar disease signatures. DEPI matches ...
Technologybased inGeneve, SWITZERLAND
ITS Water Group specializes in providing advanced chemical reagents and engineering services tailored for effective water and wastewater treatment solutions. The company focuses on delivering innovative technologies for municipal and industrial ...
Primarily used for hygienic and surgical skin treatment, the alcohol-based sanitizer from ITS Water Group offers a quick solution for disinfecting small surfaces and non-critical medical products without requiring rinsing. It acts effectively ...
Technologybased inSchlieren, SWITZERLAND
Redbiotec is a private biotech company in Zurich-Schlieren. Founded in 2006 as a spin-off of ETH Zürich, the company has won several awards, including the renowned W.A. de Vigier Award. In 2015, Pfizer acquired Redvax (a Redbiotec spin-off) for its ...
Technologybased inUrdorf, SWITZERLAND
Securecell AG specializes in pioneering advanced solutions within the biotech and MedTech industries. Their technological innovations focus on automated bioprocessing, high-throughput sampling, and the deployment of digital technologies to enhance ...
Seraccess® was forged from Securecell’s expertise in automating and digitalizing the biotechnology space. Our immense knowledge of connecting expansive bioprocessing systems, microfluidics and documenting processes down to the molecular ...
Technologybased inNew York, NEW YORK (USA)
Stemline Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. The goal of our dedicated team of scientists, specialists, researchers, and developers is to build ...
ELZONRISTM (tagraxofusp, SL-401) — ELZONRIS is a novel targeted therapy directed to the interleukin-3 (IL-3) receptor-α (CD123), a target present on a wide range of malignancies. ELZONRIS was approved by the US Food and Drug ...
Technologybased inBubendorf, SWITZERLAND
CIS Pharma is an innovator in the life science industry in the field of Oncology and Ophthalmolog. We were awarded with the European Frost & Sullivan Technology Innovation Award for our unique smart polymer technologyœ, says Christoph Schäfer, CEO ...
The Cefuroxime Application System is CIS Pharma’s patented drug/device combination for preparation and injection of cefuroxime intracameral antibiotic to prevent Endophthalmitis. It meets the cataract surgeon’s need to dilute and inject ...
Technologybased inNeuchâtel, SWITZERLAND
1DROP’s goal is to improve patient lives by enabling personalized healthcare through non-invasive diagnostic tests providing actionable health information that is accessible to everyone at any time. 1DROP facilitates the early detection, prevention ...
We are working towards defining the future of technology enabled medical diagnostics and corresponding care delivery. Our portable medical diagnostics provide real patient perspectives, clinical applications and outcomes based results. We leverage ...